Tezspire succeeds in chronic rhinosinusitis; Gilead writes down Trodelvy value
AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps.
EuropaWire4 小时
Tezspire Shows Promise in Reducing Nasal Polyp Symptoms in Phase III Trial for Chronic ...
(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...
Medscape19 小时
Treatment of Elderly Patients With Chronic Lymphocytic Leukemia
In conclusion, although age should generally determine the goal of treatment in CLL ... The incidence of chronic lymphocytic leukemia (CLL) is dramatically increased in elderly patients although ...
Health.com22 小时
What Causes Phlegm?
Sarah Jividen, RN, BSN, is a trained neuro/trauma, and emergency room nurse turned healthcare freelance writer. As a journalism major, she combined her love for writing with her passion for high ...